Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-010 - Updated Survival Outcomes of NEJ005/TCOG0902, a Randomized PII of Gefitinib and Chemotherapy in EGFR-Mutant NSCLC
09:30 - 09:30 | Presenter: Tatsuro Fukuhara | Author(s): S. Oizumi, S. Sugawara, K. Minato, T. Harada, A. Inoue, Y. Fujita, Satoshi Watanabe, K. Ito, Akihiko Gemma, Y. Demura, M. Harada, H. Isobe, I. Kinoshita, S. Morita, Kunihiko Kobayashi, K. Hagiwara, M. Kurihara, T. Nukiwa
- Abstract
Loading... -
+
P2.03-015 - Efficacy of EGFR-TKIs for EGFR Mutatnt NSCLC Patients with Central Nervous System Metastases: A Retrospective Analysis
09:30 - 09:30 | Presenter: Kenichi Koyama | Author(s): Y. Saida, T. Abe, M. Satokata, Y. Mishina, K. Sato, Satoshi Shoji, T. Tanaka, K. Nozaki, K. Ichikawa, T. Miyabayashi, T. Ota, F. Fujimori, R. Ito, R. Kondo, T. Hiura, M. Okajima, S. Miura, Satoshi Watanabe, N. Matsumoto, H. Tanaka, T. Kikuchi
- Abstract
Loading... -
+
P2.03-021 - A Phase I Study Evaluating the Combination of Afatinib, Carboplatin and Pemetrexed after Failure of 1St Generation EGFR-TKIs
09:30 - 09:30 | Presenter: Ou Yamaguchi | Author(s): Satoshi Watanabe, A. Masumoto, Y. Maeno, Y. Kawashima, O. Ishimoto, S. Sugawara, H. Yoshizawa, Kunihiko Kobayashi, T. Nukiwa
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-007 - Retrospective Analysis of Antitumor Effects and Biomarkers of Nivolumab in NSCLC Patients with EGFR Mutations
09:30 - 09:30 | Presenter: Satoshi Watanabe | Author(s): H. Tanaka, K. Nozaki, M. Sato, M. Arita, Y. Mishina, Satoshi Shoji, K. Ichikawa, R. Kondo, T. Sakagami, T. Koya, T. Kikuchi
- Abstract
Loading...